Insiders Surge: NUVECTIS PHARMA DIRECTOR Buys 50K Shares Amid Stock Dip, Hinting at Upcoming Upswing
Insider buying spree at Nuvectis Pharma signals confidence: executives buy low‑price shares after a dip, hinting at potential rebound.
3 minutes to read
